TheBitCast

Psychopharmacology and Psychiatry Updates

Autor: Psychopharmacology Institute

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Odcinki

  1. First-Episode Psychosis in Women – Psychopharmacology and Psychiatry Updates
  2. Second-Generation Antipsychotics for OCD Augmentation – Psychopharmacology and Psychiatry Updates
  3. Are Z-Drugs Safe in the First Trimester of Pregnancy? – Psychopharmacology and Psychiatry Updates
  4. Glutamatergic Augmentation in OCD – Psychopharmacology and Psychiatry Updates
  5. Schizophrenia: Which of Seven Antipsychotics Wins? – Psychopharmacology and Psychiatry Updates
  6. SSRI Dosing for OCD: Beyond FDA Guidelines – Psychopharmacology and Psychiatry Updates
  7. Trazodone for Insomnia and Comorbid Depression – Psychopharmacology and Psychiatry Updates
  8. Antipsychotics, Prolactin, and Sexual Side Effects – Psychopharmacology and Psychiatry Updates
  9. EMERGENT-5: Cobenfy and Treatment Durability – Psychopharmacology and Psychiatry Updates
  10. Antipsychotics and Weight Gain – Psychopharmacology and Psychiatry Updates
  11. EPA vs. DHA: Fish Oil and Treatment-Resistant Depression – Psychopharmacology and Psychiatry Updates
  12. AUD Medications and Hepatic Safety – Psychopharmacology and Psychiatry Updates
  13. GLP-1 Agonists in Serious Mental Illness: Current Evidence – Psychopharmacology and Psychiatry Updates
  14. Gabapentin, Topiramate & Baclofen in AUD – Psychopharmacology and Psychiatry Updates
  15. Deprescribing Benzodiazepines: When Tapering Might Do More Harm Than Good – Psychopharmacology and Psychiatry Updates
  16. Disulfiram Unpacked: Efficacy, Risks, and Liver Safety – Psychopharmacology and Psychiatry Updates
  17. GLP-1s and Lithium: What Clinicians Need to Know – Psychopharmacology and Psychiatry Updates
  18. Naltrexone for Alcohol Use Disorder: What You Should Know – Psychopharmacology and Psychiatry Updates
  19. The OPTIMUM Trial: A Roadmap for Treatment-Resistant Depression in Late Life – Psychopharmacology and Psychiatry Updates
  20. Difficult-to-Treat Depression: First, Second, and Third-Line Strategies – Psychopharmacology and Psychiatry Updates
  21. Is High-Dose Olanzapine A Clozapine Alternative? – Psychopharmacology and Psychiatry Updates
  22. CANMAT Guidelines: Herbs, Supplements, and Depression – Psychopharmacology and Psychiatry Updates
  23. Xylazine in the ED: Managing Toxicity – Psychopharmacology and Psychiatry Updates
  24. Choosing the First Step in Depression Treatment: A CANMAT Guide – Psychopharmacology and Psychiatry Updates
  25. After Delirium Clears: When to Deprescribe? – Psychopharmacology and Psychiatry Updates
  26. The Clinician's Guide to Paliperidone & Risperidone LAIs – Psychopharmacology and Psychiatry Updates
  27. Antipsychotic Switching: Six Clinical Tips – Psychopharmacology and Psychiatry Updates
  28. Mastering Long-Acting Injectables: Aripiprazole & Olanzapine – Psychopharmacology and Psychiatry Updates
  29. Predicting Lithium Response in Bipolar Disorder – Psychopharmacology and Psychiatry Updates
  30. Preventing Relapse: The Role of LAIs in Schizophrenia – Psychopharmacology and Psychiatry Updates